Abstract
The impact of managed care has been dramatic in child psychiatric services. This paper describes the clinical evolution of child mental health services in the US in the context of managed care. The paper notes the lack of information guiding the safety and effectiveness of treatment, and the authors argue that there are both clinical and ethical reasons for managed care organizations to share data about their beneficiaries treatment outcomes in an effort to improve the safety and quality of psychiatric care to children and adolescents. The authors make recommendations for changes in public accountability and call for collaboration between all parties to occur without further delay.
Keywords: child psychiatry, child and adolescent mental health, managed care, quality of care, ethics
Current Pediatric Reviews
Title: Managed Health Care and Child Mental Health Services: Where Is Horton to Hear the Whos?
Volume: 1 Issue: 1
Author(s): Michael S. Jellinek, Melissa E. Abraham, Anna C. Muriel and Susan Swick
Affiliation:
Keywords: child psychiatry, child and adolescent mental health, managed care, quality of care, ethics
Abstract: The impact of managed care has been dramatic in child psychiatric services. This paper describes the clinical evolution of child mental health services in the US in the context of managed care. The paper notes the lack of information guiding the safety and effectiveness of treatment, and the authors argue that there are both clinical and ethical reasons for managed care organizations to share data about their beneficiaries treatment outcomes in an effort to improve the safety and quality of psychiatric care to children and adolescents. The authors make recommendations for changes in public accountability and call for collaboration between all parties to occur without further delay.
Export Options
About this article
Cite this article as:
Jellinek S. Michael, Abraham E. Melissa, Muriel C. Anna and Swick Susan, Managed Health Care and Child Mental Health Services: Where Is Horton to Hear the Whos?, Current Pediatric Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573396052953507
DOI https://dx.doi.org/10.2174/1573396052953507 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of Cell Lines in the Investigation of Pharmacogenetic Loci
Current Pharmaceutical Design Recent Progress in FKBP Ligand Development
Current Molecular Pharmacology Src Kinase Inhibitors: An Update on Patented Compounds
Current Medicinal Chemistry The Pathogenesis of Lung Cancer and Chromosome 11
Current Genomics An Update of the Classical and Novel Methods Used for Measuring Fast Neurotransmitters During Normal and Brain Altered Function
Current Neuropharmacology Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation® Program: A Research Review Update
Current Hypertension Reviews The Formulation of Lipid-Based Nanotechnologies for the Delivery of Fixed Dose Anticancer Drug Combinations
Current Drug Delivery Randomised Trials of Graft Versus Host Disease Prophylaxis in Haemopoietic Stem Cell Transplantation
Reviews on Recent Clinical Trials Design and Development of Anti-Hepatitis B Virus Agents
Current Medicinal Chemistry Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets Screening for Infectious Diseases During Pregnancy: Which Test and Which Situation
Current Women`s Health Reviews Obesity and Inflammation: Colorectal Cancer Engines
Current Molecular Pharmacology The Rb Pathway and Cancer Therapeutics
Current Drug Targets RhoGEFs in Cell Motility: Novel Links Between Rgnef and Focal Adhesion Kinase
Current Molecular Medicine Controlled Somatic and Germline Copy Number Variation in the Mouse Model
Current Genomics The Antibiotic Effects of Vitamin D
Endocrine, Metabolic & Immune Disorders - Drug Targets Cancer/Testis Antigens Trigger Epithelial-Mesenchymal Transition and Genesis of Cancer Stem-Like Cells
Current Pharmaceutical Design Effects of Anticancer Drugs in Reproductive Parameters of Juvenile Male Animals and Role of Protective Agents
Anti-Cancer Agents in Medicinal Chemistry Development of a PBPK Model for Monoclonal Antibodies and Simulation of Human and Mice PBPK of a Radiolabelled Monoclonal Antibody
Current Pharmaceutical Design Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept
Current Cancer Drug Targets